Dimensional Fund Advisors LP Acquires 135,007 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

Dimensional Fund Advisors LP raised its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 10.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,488,667 shares of the medical instruments supplier's stock after buying an additional 135,007 shares during the period. Dimensional Fund Advisors LP owned about 3.68% of AngioDynamics worth $13,636,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. SBI Securities Co. Ltd. acquired a new stake in shares of AngioDynamics in the 4th quarter valued at $28,000. JPMorgan Chase & Co. increased its position in AngioDynamics by 28.7% in the third quarter. JPMorgan Chase & Co. now owns 553,161 shares of the medical instruments supplier's stock worth $4,304,000 after purchasing an additional 123,271 shares during the period. Barclays PLC lifted its position in AngioDynamics by 81.0% during the 3rd quarter. Barclays PLC now owns 83,582 shares of the medical instruments supplier's stock valued at $651,000 after purchasing an additional 37,394 shares during the period. Bank of New York Mellon Corp boosted its stake in AngioDynamics by 3.2% in the fourth quarter. Bank of New York Mellon Corp now owns 122,676 shares of the medical instruments supplier's stock valued at $1,124,000 after acquiring an additional 3,815 shares during the last quarter. Finally, Principal Financial Group Inc. bought a new stake in shares of AngioDynamics during the 4th quarter valued at $879,000. Institutional investors own 89.43% of the company's stock.

Analyst Ratings Changes

Separately, HC Wainwright reissued a "buy" rating and issued a $16.00 target price (up previously from $15.00) on shares of AngioDynamics in a research note on Monday, April 7th.

AngioDynamics Stock Performance

NASDAQ:ANGO traded down $0.17 on Friday, reaching $9.11. The company's stock had a trading volume of 278,516 shares, compared to its average volume of 557,480. AngioDynamics, Inc. has a 1-year low of $5.47 and a 1-year high of $13.50. The business's 50-day moving average price is $9.42 and its two-hundred day moving average price is $9.32. The firm has a market cap of $369.93 million, a PE ratio of -1.62 and a beta of 0.58.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last announced its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.13) by $0.16. The business had revenue of $72.00 million during the quarter, compared to analysts' expectations of $70.30 million. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The business's revenue was down 4.3% compared to the same quarter last year. As a group, sell-side analysts expect that AngioDynamics, Inc. will post -0.37 EPS for the current year.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.